Implications of cancer immunity.
D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D002462:Cell Membrane / Q000276:immunology; D002648:Child; D005326:Fetal Proteins; D005770:Gastrointestinal Neoplasms / Q000276:immunology; D006649:Histocompatibility Antigens; D006801:Humans; D007109:Immunity; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation; D008748:Methylcholanthrene; D009365:Neoplasm Regression, Spontaneous; D009369:Neoplasms / Q000209:etiology / Q000276:immunology*; D009858:Oncogenic Viruses; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000951:Antigens, Neoplasm; D005326:Fetal Proteins; D006649:Histocompatibility Antigens; D007166:Immunosuppressive Agents; D008748:Methylcholanthrene